Esperion Therapeutics ESPR Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $156.16M-7.0% | $167.85M+81.6% | $92.45M+7.4% | $86.06M-24.9% | $114.63M-20.8% | ||
| $499.27M+11.4% | $448.21M+15.5% | $388.16M+15.2% | $337.01M+16.4% | $289.62M+10.1% | ||
| $104.21M-0.9% | $105.12M-3.1% | $108.54M-5.2% | $114.47M+15.2% | $99.32M+5.1% | ||
| $459.46M-0.7% | $462.57M+28.3% | $360.46M+5.2% | $342.6M+7.5% | $318.78M-5.7% | ||
| $311K-8.0% | $338K+93.1% | $175K-12.9% | $201K-11.8% | $228K-10.2% | ||
| $56K0.0% | $56K0.0% | $56K0.0% | $56K0.0% | $56K0.0% | ||
| $462.53M-0.7% | $465.89M+28.0% | $364.02M+4.9% | $347.09M+7.1% | $324.03M-5.8% | ||
| $68.41M+5.1% | $65.07M-16.1% | $77.51M+3.8% | $74.7M+3.8% | $71.99M+39.4% | ||
| $43.53M+26.3% | $34.48M+12.4% | $30.68M+37.5% | $22.31M+391% | $4.54M-46.7% | ||
| $300.36M-0.1% | $300.81M-16.2% | $359.03M+20.2% | $298.8M+10.3% | $270.97M+10.0% | ||
| $152.67M+0.3% | $152.22M+0.4% | $151.65M— | —— | —— | ||
| $770.46M+0.3% | $767.85M-5.8% | $815.38M+4.5% | $780.59M+4.0% | $750.24M+2.4% | ||
| 480M0.0% | 480M0.0% | 480M0.0% | 480M0.0% | 480M0.0% | ||
| -$1.65B-1.6% | -$1.62B+3.7% | -$1.69B-1.9% | -$1.65B-0.8% | -$1.64B-2.5% | ||
| -$307.93M-2.0% | -$301.97M+33.1% | -$451.36M-4.1% | -$433.51M-1.7% | -$426.21M-9.6% | ||
| $462.53M-0.7% | $465.89M+28.0% | $364.02M+4.9% | $347.09M+7.1% | $324.03M-5.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Esperion Therapeutics's total assets?
- Esperion Therapeutics (ESPR) holds $462.5M in total assets, up 42.7% year over year.
- How much debt does Esperion Therapeutics have?
- Esperion Therapeutics carries $155.2M in total debt against -$307.9M of shareholders' equity, a debt-to-equity ratio of 0.75.
- How much cash does Esperion Therapeutics have?
- Esperion Therapeutics holds $156.2M in cash and equivalents.
- Can Esperion Therapeutics cover its short-term obligations?
- Its current ratio is 1.53 — current assets exceed current liabilities.
- Where does Esperion Therapeutics's balance sheet data come from?
- Every line is extracted from Esperion Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
